Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Circadian Therapeutics
Circadian Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Circadian Therapeutics
Total Funding
$2.5 M
Circadian Therapeutics Summary
Company Summary
Overview
Circadian Therapeutics is a company that develops products targeting diseases associated with circadian rhythm disruption. It offers Circaid EEG, a wearable mini-electrode device for at-home data collection.
Type
Private
Status
Active
Founded
2016
HQ
Milton, GB
|
view all locations
Website
https://circadiantherapeutics.com/
Cybersecurity rating
Sectors
Healthcare
medical devices
medtech
wearables
Homepage
Linkedin
Table of Contents
Key People
Locations
Competitors
Key People
Russell Foster,
Director & Academic Founder
Mike Snape,
Chairman
Glen Leighton,
Non-Exec Director
Julia Jones,
Chief Finance Officer
Locations
View all
2 locations detected
Milton, England
HQ
United Kingdom
Milton Park Innovation Centre, 99 Park Dr
Oxford, England
United Kingdom
New Rd
Competitors and Similar Companies
RxFunction
Healthcare - Private
Vivonics
Healthcare - Private
Recovery Force
Healthcare - Private
Otolith Labs
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top